These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103. Monoamine oxidase inhibitors as treatment for depressed patients with primary degenerative dementia (Alzheimer's disease). Jenike MA Am J Psychiatry; 1985 Jun; 142(6):763-4. PubMed ID: 4003602 [TBL] [Abstract][Full Text] [Related]
104. [Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature]. Erfurth A; Schmauss M Nervenarzt; 1993 Jan; 64(1):70-2. PubMed ID: 8437650 [TBL] [Abstract][Full Text] [Related]
106. Tranylcypromine in mind (Part I): Review of pharmacology. Ulrich S; Ricken R; Adli M Eur Neuropsychopharmacol; 2017 Aug; 27(8):697-713. PubMed ID: 28655495 [TBL] [Abstract][Full Text] [Related]
107. Antidepressant treatment with MAO-inhibitors during general and regional anesthesia: a review and case report of spinal anesthesia for lower extremity surgery without discontinuation of tranylcypromine. Krings-Ernst I; Ulrich S; Adli M Int J Clin Pharmacol Ther; 2013 Oct; 51(10):763-70. PubMed ID: 23993253 [TBL] [Abstract][Full Text] [Related]
108. Tranylcypromine: new perspectives on an "old" drug. Frieling H; Bleich S Eur Arch Psychiatry Clin Neurosci; 2006 Aug; 256(5):268-73. PubMed ID: 16927039 [TBL] [Abstract][Full Text] [Related]
109. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors. Kennedy SH J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307 [TBL] [Abstract][Full Text] [Related]